BioSpace News Archive

The demand in the global desloratadine market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

The demand in the global diabetic foot ulcers treatment market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

The demand in the global diptheria vaccine market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

ASLAN intends to resume screening as soon as government restrictions are lifted and is taking steps to open sites in Australia to accelerate recruitment

DaVita Inc., a leading provider of kidney care services, provided the following commentary regarding the COVID-19 pandemic.

AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US announced that the US Food and Drug Administration has approved the kinase inhibitor KOSELUGO™ for the treatment of pediatric patients two years of age and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.

In alignment with ongoing efforts to raise awareness about loneliness and its impact on health and well-being, Cigna is launching a pilot program to increase social connectivity among its Medicare Advantage (MA) customers during the COVID-19 pandemic.

Objective improvement in first two patients treated with opaganib in Israel who have demonstrated measurable clinical improvement within days of treatment initiation, including decreased supplemental oxygen requirements, decreased C-reactive protein (CRP) levels and increased lymphocyte levels -- One patient was treated in the ICU, was considered for intubation, and was released within days of treatment-initiation -- Opaganib was administered in addition to standard-of-care, including hy

Natera, Inc. today announced preliminary operational and financial results for the quarter ended March 31 , 2020. Natera generated total revenues of approximately $89 million to

~ Potential for PEDMARK to be the First Product for the Prevention of Cisplatin-Induced Hearing Loss in Children ~ ~ FDA Grants Priority Review and Sets a Prescription Drug User Fee Act (PDUFA) Target Action Date of August 10, 2020 ~ Research Triangle Park, N.C., April 13, 2020 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted Pri